Beneficial effects of Tong-xin-lou (herb) on myocardial no-reflow after acute myocardial infarction and reperfusion: Experiment of mini-swine model

National Medical Journal of China

Volumn 85, Issue 13, 2005, Pages 883-888

  Yang, Yue Jin ^a   Zhao, Jing Lin ^a   Jing, Zhi Cheng ^a   Wu, Yong Jian ^a   You, Shi Jie ^a   Yang, Wei Xian ^a   Meng, Liang ^a   Tian, Yi ^a   Chen, Ji Lin ^a   Gao, Run Lin ^a   Chen, Zai Jia ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Angiocardiography; Cardiovascular agents (TCD); Myocardial infarction; Myocardial reperfusion; Swine

Indexed keywords

CHINESE DRUG; EVANS BLUE; HERBACEOUS AGENT; THIOFLAVINE; TONG XIN LUO; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ARTICLE; BLOOD VOLUME; CHINESE HERB; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG CAPSULE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HEART OUTPUT; HEART RATE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOW DRUG DOSE; NONHUMAN; PATHOPHYSIOLOGY; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; SWINE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CORONARY VESSELS; DRUGS, CHINESE HERBAL; FEMALE; MALE; MYOCARDIAL INFARCTION; PHYTOTHERAPY; REPERFUSION INJURY; SWINE; SWINE, MINIATURE; VENTRICULAR FUNCTION, LEFT;

EID: 23044480912     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no-reflow' phenomenon: a predictor of complications and left ventricular remodeling in perfused anterior wall myocardial infarction. Circulation, 1996, 93: 223-228.
2. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation, 1992, 85: 1699-1705.
3. Abbo KM, Dooris M, Glaziar S. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol, 1995, 75: 778-782.
4. Morshima J. Long term prognostic impact of angiographic no-reflow phenomenon in patient treated with angioplasty for acute myocardial infarction possible involvement of left ventricular remodeling. Circulation, 1999, 100(Supple1): 451-456.
5. Gersh BJ. Optimal management of acute myocardial infarction at the down of the next millennium. Am Heart J, 1999, 138 (2pt2): 188-202.
6. Reffelmann T, Kloner RA. The "no-reflow" phenomenon: basic science and clinical correlates. Heart, 2002, 87: 162-168.
7. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation, 2002, 105: 656-662.
8. Han HP, Zhang XR. Effect of Tongxinluo capsule on function of vascular endothelium in patients with unstable angina pectoris. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2004, 13: 307.
9. Wen D, Guo DB, Tong CH. Effect of Tongxinluo capsule on function of vascular endothelium and magnesium in patients with angina pectoris. JETCM, 2004, 13: 222-223.
10. Xiao WL, Dai H, Jiang ZA. Protective effect of Tongxinluo capsule on vascular endothelial cells in patients with unstable angina pectoris. Chin J Cardiol, 2002, 30: 268.
11. Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechenism and therapies. European Heart J, 2001, 22: 729-739.
12. Madonna M, Celani F, Funaro S, et al. Myocardial contrast echography. History, methodology and clinical applications. Minerva Cardioangiol, 2003, 51: 647-660.
13. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest, 1974: 1498-1508.
14. Xu SY, Bian RL, Chen X. The methodology of pharmacological experiment. The 3rd edition. Beijing: People's Sanitation Press, 2002. 652-657.
15. Li YW, Qin LC, Su HB. Protective effect of Tongxinluo capsule on myocardial ischemia reperfusion injury in rats. Hainan Med, 2003, 14: 95-96.
16. Babbitt DG, Virmani R, Forman MB. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation, 1989, 80: 1388-1399.
17. Zhao MZ, Gao CM, Zhang YY. Experimental study in protective action of Tongxinluo capsule on myocardial ischemia reperfusion injury. Chin J Bas Med TCM, 2000, 6: 36-38.